Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pituitary Neoplasms 3 Nelson Syndrome 2 Prostatic Neoplasms 1 Pituitary ACTH Hypersecretion 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Neoplasms 1 Meningioma 1 Carcinoma, Intraductal, Noninfiltrating 1 Adrenocortical Hyperfunction 1 ACTH Syndrome, Ectopic 1

Interventions

Hyperthermic Intraperitoneal Chemotherapy 4 Cytoreduction Surgical Procedures 4 Cisplatin 3 Oxaliplatin 2 Leucovorin 2 Fluorouracil 2 volociximab 1 vandetanib 1 pembrolizumab 1 pasireotide 1 birinapant 1 alvimopan 1 Therapeutic Irrigation 1 Surgical Procedures, Operative 1 Saline Waters 1 Paclitaxel 1 Indocyanine Green 1 Folfox protocol 1 Docetaxel 1 Chemotherapy, Adjuvant 1 Cetuximab 1 Carboplatin 1 Capecitabine 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Peritoneal Neoplasms × pasireotide × Clear all

NCT04826432 2024-02-08

PASIREOCHIP

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Terminated

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡